Hypromellose (Artificial tear) eye drops 0.5% – [10 ml vial]

Protector of the corneal epithelium, has a lubricating and emollient effect, is highly viscous, increases the duration of contact of the solution with the cornea. The index of refraction of the solution is similar to natural tears. Restores, stabilizes and reproduces optical characteristics of the tear film. Extends the action of other eye drops and protects the cornea from their irritating effects. Subjective and objective improvement of condition (epithelization, reduction of hyperemia and lesions) usually comes within 3-5 days, significant improvement or complete recovery within 2-3 weeks.

-Lack of lacrimation, lagophthalmus, eyelid deformities, ectropion, conditions after eyelid plasty, corneal erosions and trophic ulcers, conditions after chemical and thermal burns of cornea and conjunctiva, bullous dystrophic corneal changes, keratopathy, microdefects of corneal epithelium, conditions after keratoplasty, keratectomy;

-for prolongation of action or elimination of irritating action of other eye drops;

-combined treatment of “dry eye” syndrome: Stevens-Johnson syndrome, Sjögren’s syndrome or disease, xerosis, keratosis (often in combination with therapeutic contact lenses);

-eye irritation caused by smoke, dust, cold, wind, sun, salt water, in allergies;

-Eye strain from prolonged computer work and driving;

Diagnostic procedures: gonioscopy, electroretinography, electro-oculography, eye ultrasound.

Hypersensitivity to the individual components of the drug, infectious eye diseases.

With caution:

Acute phase of chemical burns of the cornea and conjunctiva (until complete removal of toxic substances and necrotic tissues).

There are no data on the use of the drug in children, so the drug should be used only by the prescription of the attending physician, if the expected benefits exceed the potential risk.

Pregnancy and lactation:

There is no experience of using the drug during pregnancy and lactation. Administration during pregnancy and lactation is possible only by prescription of attending physician if the expected therapeutic effect exceeds the risk of possible side effects.